PG

Pawan Garg

Active Director Director DIN 02262031
DIN 02262031 First appointment Jul 2008 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2008
Shareholding value •••• Premium profile

About Pawan Garg

Data last updated:

Pawan Garg is a Director at Codex Biotech Private Limited (since 2008). The company operates in Chemicals. Codex Biotech Private Limited reported revenue of ₹12 Lakh (FY 2017).

DIN 02262031
Primary Designation Director
Industry Chemicals
First Appointment 18 Jul 2008
Oldest Company Age 19 yrs
Largest company Codex Biotech Private Limited · ₹12 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Codex Biotech Private Limited U24110UP2006PTC032565
Director18 Jul 20082006₹12 Lakh (FY 2017)Active

Board colleagues of Pawan Garg

NameDINCompanyDesignation
Avdhesh Kumar Gupta01462144Codex Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Codex Biotech Private Limited
Premium access

Shareholding and investment profile for Pawan Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Garg

Pawan Garg currently holds 1 directorship: Codex Biotech Private Limited (Director, since 18 Jul 2008, revenue ₹12 Lakh (FY 2017)).

Pawan Garg was first appointed on 18 Jul 2008 as Director at Codex Biotech Private Limited.

The current boards of Pawan Garg's companies include Avdhesh Kumar Gupta (Codex Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available